Randomization Procedure
Block randomization will be used in this study. Participants will be assigned in blocks of four, with two participants allocated to the intervention group and two to the control group within each block. The allocation sequence within each block will be determined randomly (e.g., AABB, ABAB, BBAA, etc.).
The unit of randomization is the individual participant (individual randomization). Each eligible patient will be independently assigned to one of the two study groups, namely, the cefazolin-only group or the cefazolin-plus-metronidazole group, according to the randomization list.
Randomization will be performed using a randomization list and a randomization table, which will also be used for the preparation of the medication packages.
Generation of the Randomization Sequence
The allocation sequence will be generated using block randomization with blocks of four participants. The order of allocation within each block will be determined randomly (e.g., AABB, ABAB, and BBAA).
Allocation Concealment
To maintain allocation concealment, the study will be conducted using a double-blind design. Medication packages will be prepared in advance according to the randomization table. Each package will contain two syringes of identical volume and appearance. In the control group, the second syringe will contain normal saline, whereas in the intervention group, it will contain 500 mg of metronidazole.
The surgical team and outcome assessors will receive only the package number and will remain unaware of the actual contents of the medications and group assignments. Only the individual responsible for preparing the medication packages will have access to the group allocation information. The allocation code will be disclosed only in emergency situations.